Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Neovasc Inc. NVCN

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter... see more

NDAQ:NVCN - Post Discussion

Neovasc Inc. > Delisting
View:
Post by Barewood on Jul 09, 2018 11:23am

Delisting

Fred will get his extension!
Comment by logisticstrader on Jul 10, 2018 5:59pm
what filings are they deficient on? the worst that could happen,is they trade on the pinks
Comment by Barewood on Jul 10, 2018 9:41pm
NASDAQ's $1.00 minimum Bid share price must be held for 10 days straight. They have the "voted" reverse split as a bargaining chip which they intend to use at their hearing on the 13th. I don't see any problem with them getting an extension to the end of the Year.
Comment by Stonehouse97 on Jul 11, 2018 6:00am
They are deluding themselves if they think it will hold at $1 after RS.
Comment by logisticstrader on Jul 11, 2018 7:46am
r/s never work
Comment by Barewood on Jul 12, 2018 12:08am
Stonehouse, Neovasc is not effecting a R/S yet if at all. I think once it has NASDAQ approval, shareholder confidence will be back in full swing. Getting its clinicals on the way in the  U.S., which by the way has already been given the green light, will move this thing big time.
Comment by logisticstrader on Jul 11, 2018 7:44am
they would be better off going otc,rather than r/sall that's going to do is drop the price from a dollar back to a nickel
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities